Abstract
Recent advances in growth factor therapy for the treatment of ischemic disease of the heart and peripheral vasculature offer hope for a novel strategy that is based on the generation of a new blood supply. Members of the fibroblast growth factor and vascular endothelial growth factor families and several other molecules have all been shown to induce significant angiogenesis in animal models of acute or chronic, myocardial or peripheral ischemia. In addition, it is known that arteries from specific regions in the arterial tree have various developmental origins. This may be one explanation for why arteries of different parts of the arterial tree undergo differential changes during the pathogenesis of vascular disease. There is speculation over several fundamental questions concerning the origin of vessel wall cells and the mechanisms that regulate their development and differentiation. Here we discuss what is known to date about the differential developmental origin of arteries and the possible consequences for therapeutic angiogenesis.
Keywords: ischemic disease, fibroblast growth, disrupted cell contact, hematopoietic progenitors, smooth muscle cells, mesodermal tissue, cytoskeletal markers desmin, vascular endothelial cells, mesenchymal transition failures, angiogenic processes
Current Medicinal Chemistry
Title: Vasculogenesis and Angiogenesis Depend on the Developmental Origin in the Arterial Tree
Volume: 9 Issue: 17
Author(s): Masumi Shimizu, Jaroslav Pelisek and Sigrid Nikol
Affiliation:
Keywords: ischemic disease, fibroblast growth, disrupted cell contact, hematopoietic progenitors, smooth muscle cells, mesodermal tissue, cytoskeletal markers desmin, vascular endothelial cells, mesenchymal transition failures, angiogenic processes
Abstract: Recent advances in growth factor therapy for the treatment of ischemic disease of the heart and peripheral vasculature offer hope for a novel strategy that is based on the generation of a new blood supply. Members of the fibroblast growth factor and vascular endothelial growth factor families and several other molecules have all been shown to induce significant angiogenesis in animal models of acute or chronic, myocardial or peripheral ischemia. In addition, it is known that arteries from specific regions in the arterial tree have various developmental origins. This may be one explanation for why arteries of different parts of the arterial tree undergo differential changes during the pathogenesis of vascular disease. There is speculation over several fundamental questions concerning the origin of vessel wall cells and the mechanisms that regulate their development and differentiation. Here we discuss what is known to date about the differential developmental origin of arteries and the possible consequences for therapeutic angiogenesis.
Export Options
About this article
Cite this article as:
Shimizu Masumi, Pelisek Jaroslav and Nikol Sigrid, Vasculogenesis and Angiogenesis Depend on the Developmental Origin in the Arterial Tree, Current Medicinal Chemistry 2002; 9 (17) . https://dx.doi.org/10.2174/0929867023369321
DOI https://dx.doi.org/10.2174/0929867023369321 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Magnesium and Anaesthesia
Current Drug Targets Regular Physical Activity and Vascular Aging
Current Pharmaceutical Design Genomics, Proteomics and Metabolomics Approaches for Predicting Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients
Current Diabetes Reviews Advanced Glycation End Products: Association with the Pathogenesis of Diseases and the Current Therapeutic Advances
Current Clinical Pharmacology Strategies for Diabetes Prevention Before and After Pregnancy in Women with GDM
Current Diabetes Reviews Glycation and Hypoxia: Two Key Factors for Adipose Tissue Dysfunction
Current Medicinal Chemistry Adiponectin: An Endothelium-Derived Vasoprotective Factor?
Current Vascular Pharmacology Symptomatic Improvement, Increased Life-Span and Sustained Cell Homing in Amyotrophic Lateral Sclerosis After Transplantation of Human Umbilical Cord Blood Cells Genetically Modified with Adeno-Viral Vectors Expressing a Neuro-Protective Factor and a Neural Cell Adhesion Molecule
Current Gene Therapy Toxins of Animal Venoms and Inhibitors: Molecular and Biotechnological Tools Useful to Human and Animal Health
Current Topics in Medicinal Chemistry Circadian Rhythm of Blood Pressure in Diabetes Mellitus: Evidence, Mechanisms and Implications
Current Diabetes Reviews Editorial [Hot Topic: Neural Control of the Vasculature: Pharmacological Targets in Vascular Disease (Guest Editors: Andrzej Loesch and Michael R. Dashwood)]
Current Vascular Pharmacology Meloxicam Prevents Load-Induced Cardiac Hypertrophy in Mice
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Stable Angina Pectoris: Current Medical Treatment
Current Pharmaceutical Design A Molecular Bridge: Connecting Type 2 Diabetes and Alzheimer’s Disease
CNS & Neurological Disorders - Drug Targets The Role of Vasopressin in Affective Disorders: Possible Targets of Intervention
Central Nervous System Agents in Medicinal Chemistry Advanced Glycation End Products (AGEs), Oxidative Stress and Diabetic Retinopathy
Current Pharmaceutical Biotechnology Epigenetics in the Cerebrovascular System: Changing the Code without Altering the Sequence
Current Neurovascular Research Ethnicity and Inflammatory Pathways - Implications for Vascular Disease, Vascular Risk and Therapeutic Intervention
Current Medicinal Chemistry Current Status of Therapeutic Angiogenesis with Protein, Gene and Cell Therapy
Current Drug Therapy Epigenetic Effects of Cadmium in Cancer: Focus on Melanoma
Current Genomics